Issue 8, 2014

Bioactive oligosaccharide natural products

Abstract

Covering up to December 2013

Oligosaccharide natural products target a wide spectrum of biological processes including disruption of cell wall biosynthesis, interference of bacterial translation, and inhibition of human α-amylase. Correspondingly, oligosaccharides possess the potential for development as treatments of such diverse diseases as bacterial infections and type II diabetes. Despite their potent and selective activities and potential clinical relevance, isolated bioactive secondary metabolic oligosaccharides are less prevalent than other classes of natural products and their biosynthesis has received comparatively less attention. This review highlights the unique modes of action and biosynthesis of four classes of bioactive oligosaccharides: the orthosomycins, moenomycins, saccharomicins, and acarviostatins.

Graphical abstract: Bioactive oligosaccharide natural products

Article information

Article type
Review Article
Submitted
05 Dec 2013
First published
02 Jun 2014

Nat. Prod. Rep., 2014,31, 1026-1042

Author version available

Bioactive oligosaccharide natural products

E. K. McCranie and B. O. Bachmann, Nat. Prod. Rep., 2014, 31, 1026 DOI: 10.1039/C3NP70128J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements